Home > PE Ratio > JUBILANT PHARMOVA

JUBILANT PHARMOVA
PE (Price/Earnings) Ratio

The Current P/E Ratio of JUBILANT PHARMOVA is 34.13.

Share Price ₹1,226.5Dec 03,2024
Market Cap ₹19,538.1 Cr
Earnings-TTM₹572.5 CrTTM-Consolidated Results
Price/Earnings34.13xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results
JUBILANT PHARMOVA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of JUBILANT PHARMOVA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of JUBILANT PHARMOVA is calculated as :

Current Market Cap [ ₹19,538.1 Cr] as on Dec 03,2024

(/) Earnings [ ₹572.5 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 34.13x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for JUBILANT PHARMOVA , the investors are currently willing to pay 34.13 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JUBILANT PHARMOVA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of JUBILANT PHARMOVA over the last five years.

Historical PE (Price/Earnings) ratio chart of JUBILANT PHARMOVA


PE Ratio Performance Analysis for JUBILANT PHARMOVA

- JUBILANT PHARMOVA 's latest p/e ratio is 34.13x.

- JUBILANT PHARMOVA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 29.76x.

- JUBILANT PHARMOVA 's operated at median p/e ratio of 12.96x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JUBILANT PHARMOVA 's p/e ratio peaked in Mar2024 at 116.5x.

- JUBILANT PHARMOVA 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does JUBILANT PHARMOVA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
JUBILANT PHARMOVA 572.5034.1319,538.1
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.75431,544.0
CIPLA LTD4,485.2227.63123,920.0
DR REDDYS LABORATORIES LTD5,406.8018.91102,224.0
ZYDUS LIFESCIENCES LTD4,298.9022.9998,832.3
DIVIS LABORATORIES LTD1,836.0089.80164,865.0
MANKIND PHARMA LTD2,124.8648.25102,527.0
TORRENT PHARMACEUTICALS LTD1,802.0063.14113,772.0
LUPIN LTD2,651.9435.8194,953.0
AUROBINDO PHARMA LTD3,598.8320.4473,544.0
ABBOTT INDIA LTD1,284.6647.0560,440.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JUBILANT PHARMOVA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.91x
Max industry PE 89.80x
Median industry PE 35.81x
Average industry PE 40.63x



You may also like the below Video Courses